Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.bajajhealth.com | |
Market Cap | 1,076.06 Cr. | |
Enterprise Value(EV) | 1,432.98 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 22.94 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 17.00 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 33.61 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 129.31 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 3.02 | Calculated using Price: 389.90 |
Dividend Yield | 0.38 | Period Ending 2022-03 |
No. of Shares Subscribed | 2.76 Cr. | 27,598,400 Shares |
FaceValue | 5 | |
Company Profile | ||
Bajaj Healthcare is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs) caters to various therapeutic segments. |
1 Day |
|
-0.95% |
1 Week |
|
-3.90% |
1 Month |
|
-5.06% |
3 Month |
|
+13.20% |
6 Month |
|
-1.78% |
1 Year |
|
-10.24% |
2 Year |
|
+68.38% |
5 Year |
|
+316.02% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 7.31 | 22.38 | 19.60 | 10.77 | 17.68 | 20.18 | 18.92 | 38.09 | 24.33 | |
Return on Capital Employed (%) | 10.67 | 19.16 | 18.00 | 14.52 | 18.25 | 19.75 | 19.47 | 35.91 | 20.00 | |
Return on Assets (%) | 1.53 | 4.50 | 4.12 | 3.65 | 6.23 | 6.10 | 8.28 | 19.14 | 11.45 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 31 | 82 | 89 | 99 | 114 | 129 | 178 | 258 | 328 | 357 | |
Non Curr. Liab. | 14 | 22 | 32 | 28 | 23 | 20 | 27 | 85 | 71 | 69 | |
Curr. Liab. | 99 | 85 | 88 | 93 | 131 | 117 | 138 | 183 | 322 | 400 | |
Minority Int. | |||||||||||
Equity & Liab. | 145 | 189 | 209 | 219 | 268 | 267 | 343 | 526 | 721 | 826 | |
Non Curr. Assets | 59 | 110 | 131 | 128 | 129 | 130 | 175 | 267 | 323 | 356 | |
Curr. Assets | 86 | 79 | 78 | 91 | 140 | 137 | 168 | 258 | 398 | 469 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 145 | 189 | 209 | 219 | 268 | 267 | 343 | 526 | 721 | 826 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 186 | 197 | 200 | 207 | 290 | 325 | 410 | 657 | 680 | 716 | |
Other Income | 0 | 0 | 0 | 2 | 2 | 1 | 7 | 7 | 1 | 1 | |
Total Income | 186 | 197 | 201 | 210 | 292 | 326 | 417 | 664 | 681 | 718 | |
Total Expenditure | -166 | -168 | -170 | -176 | -250 | -282 | -362 | -521 | -561 | -601 | |
PBIDT | 20 | 29 | 30 | 33 | 42 | 44 | 55 | 143 | 120 | 117 | |
Interest | -7 | -8 | -8 | -8 | -8 | -8 | -7 | -8 | -13 | -16 | |
Depreciation | -9 | -9 | -9 | -11 | -11 | -11 | -12 | -16 | -18 | -22 | |
Taxation | -1 | -5 | -5 | -6 | -8 | -8 | -11 | -36 | -18 | -15 | |
Exceptional Items | |||||||||||
PAT | 2 | 8 | 8 | 8 | 15 | 16 | 25 | 83 | 71 | 63 | |
Adjusted EPS | 1 | 3 | 3 | 3 | 6 | 6 | 9 | 30 | 26 | 23 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 15 | 17 | 28 | 25 | 22 | 17 | 25 | 21 | 44 | 1 | |
Cash Fr. Inv. | -8 | -9 | -17 | -31 | -8 | -12 | -13 | -28 | -109 | -75 | |
Cash Fr. Finan. | -7 | -8 | -11 | 5 | -13 | 2 | -13 | 3 | 75 | 62 | |
Net Change | 0 | 1 | 0 | 0 | 0 | 7 | 0 | -4 | 10 | -12 | |
Cash & Cash Eqvt | 0 | 1 | 1 | 0 | 1 | 8 | 8 | 4 | 14 | 2 |
Fri, 13 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 we herewith enclose certificate received from Link Intime India Private Limited The Registrar and Transfer Agent of the Company for the quarter ended 31st December 2022.Kindly take the same on your record. |
Fri, 30 Dec 2022
Closure of Trading Window Trading Window Closure |
Fri, 16 Dec 2022
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Anil Champalal Jain |
Wed, 25 Jan 2023 |
|
|
|
|
|